According to Bloomberg, Biohaven Pharmaceutical (BHVN) approached by potential bidders
Biohaven Pharmaceutical Holding Co., (BHVN) a developer of migraine treatments, is exploring options including a possible sale of the company after attracting interest from potential bidders,
Read More